Hikal Share Price Today | Stock Price & Hikal Share Screener
As of October 5, 2026, the live Hikal share price (NSE: HIKAL) is ₹214.45 on NSE and ₹214.45 on BSE, down 1.69% from the previous close, with shares trading between ₹213.28 and ₹221.35 in today's trading session, and a 52-week range of ₹147.08–₹256.15. Check Hikal 52-week for the annual price range and momentum. Use the Hikal stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Hikal opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹411 and net income of ₹-7, with EBITDA of ₹45, an operating margin of 9.0% and a profit margin of -1.7%.
Hikal Share Price Chart
Track the current stock price of Hikal with an interactive chart. Analyse HIKAL share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Hikal stock quote in one place.
The quote of ₹214.45 sits between the 52-week low of ₹147.08 and the 52-week high of ₹256.15, and the latest session moved -1.69% from the previous close.
Hikal Company Profile - Fundamental Screener
Screen Hikal company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for HIKAL shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE475B01022.
Company Details
Classification
Identifiers and Leadership
Hikal Balance Sheet Screener
Screen HIKAL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹2,365, down from ₹2,529 in 2025.
Latest statistics put total assets at ₹2,365 and shareholder funds at ₹1,199, with a leverage ratio of 0.59.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets |
||||||||||
| Total Assets | 2,365 | 2,529 | 2,487 | 2,386 | 2,213 | 1,913 | 1,768 | 1,686 | 1,542 | 1,380 |
| Current Assets | 884 | 995 | 967 | 939 | 964 | 879 | 775 | 830 | 690 | 577 |
| Fixed Assets | 1,333 | 1,365 | 1,071 | 948 | 880 | 713 | 735 | 713 | 634 | 668 |
Liabilities |
||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 488 | 477 | 543 | 591 | 376 | 323 | 355 | 327 | 312 | 334 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||||
| Total Equity | 1,199 | 1,262 | 1,188 | 1,134 | 1,068 | 933 | 817 | 756 | 669 | 605 |
| Share Capital | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 16 | 16 |
| Reserves & Surplus | 1,174 | 1,238 | 1,163 | 1,109 | 1,043 | 909 | 792 | 732 | 653 | 589 |
Hikal Income Statement Screener - Profit & Revenue Analysis
Screen Hikal income statement and profit fundamentals. Analyze HIKAL quarterly results. Hikal reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Jun, revenue was ₹411 and net profit was ₹-7, equal to earnings per unit of ₹-0.60, at an operating margin of 9%.
In that period expenses were ₹366, interest cost ₹15 and tax ₹-3. The next period listed, 2026-Mar, shows revenue of ₹524 and net profit of ₹14.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 411 | 524 | 494 | 318 | 372 | 551 | 443 | 451 | 404 | 513 | 439 | 432 | 387 | 538 | 541 |
| Expenses | 366 | 461 | 450 | 311 | 355 | 429 | 376 | 378 | 349 | 420 | 383 | 377 | 338 | 457 | 466 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | 45 | 63 | 44 | 7 | 17 | 122 | 67 | 73 | 56 | 94 | 56 | 55 | 49 | 81 | 75 |
| Operating Profit % | 9.00% | 11.00% | 8.00% | 2.00% | 4.00% | 22.00% | 14.00% | 16.00% | 14.00% | 18.00% | 13.00% | 12.00% | 13.00% | 15.00% | 14.00% |
| Depreciation | 43 | 42 | 41 | 41 | 39 | 38 | 33 | 32 | 32 | 32 | 29 | 29 | 28 | 27 | 28 |
| Interest | 15 | 15 | 16 | 15 | 17 | 18 | 19 | 19 | 20 | 15 | 14 | 13 | 14 | 13 | 13 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | -10 | 8 | -9 | -47 | -30 | 68 | 24 | 25 | 7 | 47 | 22 | 17 | 10 | 49 | 36 |
| Tax | -3 | -6 | -3 | -12 | -8 | 18 | 7 | 7 | 2 | 13 | 6 | 4 | 3 | 13 | 9 |
| Net Profit | -7 | 14 | -6 | -35 | -22 | 50 | 17 | 18 | 5 | 34 | 16 | 13 | 7 | 36 | 26 |
| EPS | -0.60 | 1.17 | -0.48 | -2.83 | -1.82 | 4.07 | 1.39 | 1.48 | 0.41 | 2.76 | 1.31 | 1.02 | 0.56 | 2.92 | 2.14 |
Hikal Cash Flow Screener - Liquidity Fundamentals
Screen HIKAL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹302, and net cash flow was an outflow of ₹3.
Over the same period, investing activities used ₹145 and financing activities used ₹160.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||||
| Operating Activities | 302 | 280 | 187 | 315 | 294 | 229 | 285 | 186 | 139 | 164 |
| Investing Activities | -145 | -137 | -174 | -292 | -284 | -156 | -164 | -125 | -110 | -102 |
Financing and Net Cash | ||||||||||
| Financing Activities | -160 | -144 | -27 | -8 | -6 | -97 | -101 | -55 | -25 | -63 |
| Net Cash Flow | -3 | 0 | -14 | 15 | 4 | -24 | 20 | 6 | 4 | -2 |
Hikal Shareholding Pattern Screener
See Hikal shareholding pattern with promoter, FII, and DII holdings. Check Hikal promoter holding and ownership changes for HIKAL on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Jun, promoters held 68.85%, foreign institutions 0.99%, domestic institutions 7.24% and the public 17.84%, spread across 73,527 shareholders.
The shareholder count was 73,527 in 2026-Jun, compared with 74,270 in 2026-Mar.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 68.85% | 68.85% | 68.85% | 68.85% | 68.85% | 68.85% | 68.85% | 68.85% |
Institutional Investors | ||||||||
| FII Holding | 0.99% | 1.43% | 2.30% | 4.23% | 5.36% | 5.69% | 6.06% | 6.78% |
| DII Holding | 7.24% | 7.20% | 7.05% | 5.16% | 4.02% | 3.80% | 3.48% | 3.58% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 17.84% | 17.18% | 16.77% | 16.66% | 16.75% | 16.57% | 16.64% | 15.81% |
| Other Holding | 5.09% | 5.34% | 5.02% | 5.10% | 5.02% | 5.08% | 4.97% | 4.99% |
| Shareholder Count | 73,527 | 74,270 | 74,117 | 73,404 | 71,391 | 68,907 | 71,801 | 71,912 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Hikal. Hikal dividend yield can be compared with peers and other stocks in the market.
The latest dividend recorded was ₹0.60 per unit for 2026-March, a yield of 0.28%, compared with ₹1.40 for 2025-March.
Dividends are listed for 10 periods, with the three most recent payouts at ₹0.60, ₹1.40 and ₹1.20 per unit.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.60 | 0.28% |
| 2025-March | ₹1.40 | 0.95% |
| 2024-March | ₹1.20 | 0.30% |
| 2023-March | ₹1.20 | 0.45% |
| 2022-March | ₹1.60 | 0.57% |
| 2021-March | ₹2.00 | 0.50% |
| 2020-March | ₹1.20 | 0.84% |
| 2019-March | ₹1.20 | 1.72% |
| 2018-March | ₹1.20 | 0.69% |
| 2017-March | ₹1.20 | 0.87% |
Hikal Stock Index Membership - Nifty & Sensex
See which indices include Hikal stock. Check HIKAL index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
The company is listed in 5 indices, including BSE 1000.
Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX SMLCAP, NIFTY MICROCAP250.
Complete Index List
Hikal Market Events Screener - Corporate Actions
Get Hikal corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Hikal stock events that may affect HIKAL share price, along with derivatives, futures and options activity and sector gainers.
15 corporate actions are listed, the most recent entry being Annual General Meeting dated September 23, 2026, with a record date of September 23, 2026.
It is followed by Dividend dated September 4, 2026 and Quarterly Result Announcement dated August 6, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-23 | 2026-09-23 | Annual General Meeting | NA | 9.35% |
| 2026-09-04 | 2026-09-04 | Dividend | ₹ 0.40 /share | 10.77% |
| 2026-08-06 | 2026-08-06 | Quarterly Result Announcement | NA | 5.19% |
| 2026-05-27 | 2026-05-27 | Quarterly Result Announcement | NA | 6.86% |
| 2026-02-17 | 2026-02-17 | Dividend | ₹ 0.20 /share | 10.78% |
| 2026-02-11 | 2026-02-11 | Quarterly Result Announcement | NA | -3.28% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -0.76% |
| 2025-09-23 | 2025-09-23 | Annual General Meeting | NA | -14.46% |
| 2025-09-02 | 2025-09-02 | Dividend | ₹ 0.80 /share | -37.12% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | -6.81% |
| 2025-05-14 | 2025-05-14 | Quarterly Result Announcement | NA | 2.48% |
| 2025-02-07 | 2025-02-08 | Dividend | ₹ 0.60 /share | 5.04% |
| 2025-02-04 | 2025-02-04 | Quarterly Result Announcement | NA | 6.12% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | 1.74% |
| 2024-09-17 | 2024-09-17 | Annual General Meeting | NA | 17.36% |
Hikal Competitors Screener - Peer Stocks Comparison
Screen HIKAL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 432,120 | 36.04 | 61,674 | 12.69% | 11,565 | 36.68 |
| Divis Laboratories | 245,532 | 84.24 | 11,067 | 13.95% | 2,568 | 51.70 |
| Torrent Pharmaceuticals | 181,333 | 84.71 | 13,886 | 20.34% | 2,138 | 41.12 |
| Zydus Life Science | 114,284 | 25.27 | 27,658 | 17.64% | 5,026 | 47.64 |
| Cipla | 108,576 | 32.50 | 29,045 | 2.24% | 3,870 | 34.78 |
| Laurus Labs | 107,198 | 98.20 | 6,868 | 22.01% | 890 | 58.70 |
| Mankind Pharma | 104,707 | 50.04 | 14,636 | 14.85% | 1,938 | 61.75 |
| Dr Reddys Laboratories | 100,679 | 32.41 | 35,059 | 3.90% | 4,158 | 53.84 |
| Aurobindo Pharma | 96,479 | 25.84 | 34,145 | 5.56% | 3,503 | 50.30 |
| Lupin | 92,885 | 16.82 | 29,039 | 26.75% | 5,356 | 31.59 |
Hikal Company Announcements - News & Reports Screener
Screen HIKAL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated October 3, 2026.
The next most recent announcements are dated October 3, 2026 and October 3, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-10-03 | Announcement under Regulation 30 (LODR)-Resignation of Director | - |
| 2026-10-03 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-10-03 | Board Meeting Outcome for Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015- Outcome Of Board Meeting | - |
| 2026-10-01 | Disclosure Under Regulation 30 Of SEBI (LODR) 2015 - ESG Rating | - |
| 2026-09-30 | Closure of Trading Window | - |
| 2026-09-23 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-09-23 | Voting Results Of The 38Th AGM Of The Company. | - |
| 2026-09-23 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-09-23 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-09-22 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-09-02 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-09-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-31 | Letter To Members Pursuant To Regulation 36(1)(B) Of SEBI (LODR) Regulations 2015 | - |
| 2026-08-31 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-08-31 | Reg. 34 (1) Annual Report. | - |
| 2026-08-31 | Notice Of The 38Th Annual General Meeting Of The Company | - |
| 2026-08-27 | Communication To Shareholders-Intimation Of Tax Deduction On Dividend. | - |
| 2026-08-27 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-26 | Date Of AGM Of The Company For FY 2025-26 | - |
| 2026-08-26 | Announcement under Regulation 30 (LODR)-Change in Management | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹214.45, within a 52-week range of ₹147.08 to ₹256.15. The P/E ratio is -79.49 and the P/B ratio is 2.24, with earnings per unit of ₹-3.96. Market capitalisation stands at ₹2,689.68 Cr and the dividend yield is 0.28%. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.